Under construction – not a live service
Sign in
Taking people in TürkiyeNo phase

Diet or Enema for Bowel Preparation Before Laparoscopic Endometrial Cancer Surgery

Compares a 3-day diet with a rectal enema before endometrial cancer surgery.

Plain-language title generated from the registry record
Registry title: Low-Residue Diet Versus Rectal Enema Before Laparoscopic Surgery for Endometrial Cancer

Key facts

Where
Istanbul, TürkiyeSee the site

AI summary: who the study is looking for

From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.

The trial is looking for women with endometrial cancer who are planned for keyhole (laparoscopic) surgery. It compares a 3-day low-residue diet with a rectal enema before surgery.

Age
18 to 90 years
Sex
Women only
Disease stage
Endometrial cancer, planned for elective laparoscopic surgery

Main reasons for not taking part

  • Planned open (abdominal) surgery
  • Known allergy or contraindication to sodium phosphate rectal enema
  • Age over 90 years
  • Refusal or inability to give written informed consent

Read by machine on 13 November 2026.

Could this be for you?

Answer for yourself. This is not a decision: only the study team can say whether you can take part.

  • Are you between 18 and 90 years old?

Source: NCT07702799, who can take part

Where in Türkiye

  • Başakşehir Çam and Sakura City HospitalIstanbul, TürkiyeContact: mahmut yassaTaking people

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Trial details

Who runs it
Mahmut Yassa
Trial code
NCT07702799
Record updated
17 July 2026
Original description
The goal of this clinical trial is to compare a standardized 3-day bowel preparation protocol with a rectal enema before laparoscopic surgery for endometrial cancer. The study will evaluate whether the dietary bowel preparation protocol can be used instead of a rectal enema while maintaining an adequate surgical view during surgery.Read full original descriptionShow less

Low-Residue Diet Versus Rectal Enema Before Laparoscopic Endometrial Cancer Surgery: A Prospective Randomized Controlled Trial

The goal of this clinical trial is to compare a standardized 3-day bowel preparation protocol with a rectal enema before laparoscopic surgery for endometrial cancer. The study will evaluate whether the dietary bowel preparation protocol can be used instead of a rectal enema while maintaining an adequate surgical view during surgery.

The main questions it aims to answer are:

* Can the dietary bowel preparation protocol provide surgical exposure comparable to a rectal enema? * Can the dietary bowel preparation protocol reduce the minimum Trendelenburg position and pneumoperitoneum pressure required to obtain an adequate surgical view? * Does either bowel preparation method cause more discomfort or side effects before surgery?

Researchers will compare a standardized 3-day bowel preparation protocol with a rectal enema before surgery.

Participants will:

* Be randomly assigned to receive either a standardized 3-day bowel preparation protocol or a rectal enema before surgery. * Undergo standard laparoscopic surgery for endometrial cancer. * Have surgical exposure, the minimum Trendelenburg position, the minimum pneumoperitoneum pressure, operative outcomes, postoperative recovery, and bowel preparation-related symptoms and discomfort assessed as part of routine clinical care.

Inclusion: Female participants aged 18 to 90 years; Scheduled to undergo elective laparoscopic surgery for endometrial cancer; Willing and able to provide written informed consent.

Exclusion: Planned open (abdominal) surgery; Known allergy or contraindication to sodium phosphate rectal enema; Age over 90 years; Refusal or inability to provide written informed consent.

ClinicalTrials.gov NCT07702799